We are a biotech start-up company that emerged as a spin off venture of Institute of Life Sciences, a autonomous institute funded by Department of Biotechnology, Government of India. Byonox private limited focuses on advancing Nitric Oxide (NO) Biology with an approach to develop Drugs/Pharmaceuticals that enhance body’s ability to resist infections and for management of other metabolic diseases such as Hypertension, Diabetes etc. through cutting-edge research and innovation. NO is involved in a variety of physiological processes. It plays an integral role in defence against bacterial, viral and parasitic pathogens, immune cell signalling and biochemical pathways and in regulating pathways of host inflammation. We discovered small molecules NOSIP inhibitors (patent protected in India, EU and USA) that enhance body’s ability to make endogenous Nitric Oxide.